JoAnn D. Bradley

Potent Reduction of Apolipoprotein B and Low-Density Lipoprotein Cholesterol by Short-Term Administration of an Antisense Inhibitor of Apolipoprotein B

John J.P. Kastelein, Mark K. Wedel, Brenda F. Baker et al. · Circulation · 2006 · 357 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Dissolution of multicomponent microbubbles in the bloodstream: 2. experiment

Alexey Kabalnov, JoAnn D. Bradley, Steven Flaim et al. · Ultrasound in Medicine & Biology · 1998 · 135 citations

Pharmacy, Pharmaceutics, Pharmacokinetics +11

B-Type Natriuretic Peptide Levels in Congenital Heart Disease

C. G. Cowley, JoAnn D. Bradley, Robert E. Shaddy · Pediatric Cardiology · 2004 · 113 citations

Medicine, Cardiology, Physiology +11

Lack of Pharmacokinetic Interaction for ISIS 113715, a 2???-0-Methoxyethyl Modified Antisense Oligonucleotide Targeting Protein Tyrosine Phosphatase 1B Messenger RNA, with Oral Antidiabetic Compounds Metformin, Glipizide or Rosiglitazone

Richard S. Geary, JoAnn D. Bradley, Tanya Watanabe et al. · Clinical Pharmacokinetics · 2006 · 49 citations

Medicine, Pharmacokinetics, Pharmacology +16

Oxygen Delivery Augmentation by Low-Dose Perfluorochemical Emulsion During Profound Normovolemic Hemodilution

Peter E. Keipert, N. S. Faithfull, JoAnn D. Bradley et al. · Advances in experimental medicine and biology · 1994 · 48 citations

Veterinary Medicine, Hematology, Drug Delivery +12